303 related articles for article (PubMed ID: 34801112)
1. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial.
Sissoko MS; Healy SA; Katile A; Zaidi I; Hu Z; Kamate B; Samake Y; Sissoko K; Mwakingwe-Omari A; Lane J; Imeru A; Mohan R; Thera I; Guindo CO; Dolo A; Niare K; Koïta F; Niangaly A; Rausch KM; Zeguime A; Guindo MA; Bah A; Abebe Y; James ER; Manoj A; Murshedkar T; Kc N; Sim BKL; Billingsley PF; Richie TL; Hoffman SL; Doumbo O; Duffy PE
Lancet Infect Dis; 2022 Mar; 22(3):377-389. PubMed ID: 34801112
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial.
Sissoko MS; Healy SA; Katile A; Omaswa F; Zaidi I; Gabriel EE; Kamate B; Samake Y; Guindo MA; Dolo A; Niangaly A; Niaré K; Zeguime A; Sissoko K; Diallo H; Thera I; Ding K; Fay MP; O'Connell EM; Nutman TB; Wong-Madden S; Murshedkar T; Ruben AJ; Li M; Abebe Y; Manoj A; Gunasekera A; Chakravarty S; Sim BKL; Billingsley PF; James ER; Walther M; Richie TL; Hoffman SL; Doumbo O; Duffy PE
Lancet Infect Dis; 2017 May; 17(5):498-509. PubMed ID: 28216244
[TBL] [Abstract][Full Text] [Related]
3. PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial.
Coulibaly D; Kone AK; Traore K; Niangaly A; Kouriba B; Arama C; Zeguime A; Dolo A; Lyke KE; Plowe CV; Abebe Y; Potter GE; Kennedy JK; Galbiati SM; Nomicos E; Deye GA; Richie TL; James ER; Kc N; Sim BKL; Hoffman SL; Doumbo OK; Thera MA; Laurens MB;
EClinicalMedicine; 2022 Oct; 52():101579. PubMed ID: 35928033
[TBL] [Abstract][Full Text] [Related]
4. DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection.
Sulyok M; Rückle T; Roth A; Mürbeth RE; Chalon S; Kerr N; Samec SS; Gobeau N; Calle CL; Ibáñez J; Sulyok Z; Held J; Gebru T; Granados P; Brückner S; Nguetse C; Mengue J; Lalremruata A; Sim BKL; Hoffman SL; Möhrle JJ; Kremsner PG; Mordmüller B
Lancet Infect Dis; 2017 Jun; 17(6):636-644. PubMed ID: 28363637
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults.
Sagara I; Healy SA; Assadou MH; Gabriel EE; Kone M; Sissoko K; Tembine I; Guindo MA; Doucoure M; Niaré K; Dolo A; Rausch KM; Narum DL; Jones DL; MacDonald NJ; Zhu D; Mohan R; Muratova O; Baber I; Coulibaly MB; Fay MP; Anderson C; Wu Y; Traore SF; Doumbo OK; Duffy PE
Lancet Infect Dis; 2018 Sep; 18(9):969-982. PubMed ID: 30061051
[TBL] [Abstract][Full Text] [Related]
6. Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of
Jongo SA; Shekalaghe SA; Church LWP; Ruben AJ; Schindler T; Zenklusen I; Rutishauser T; Rothen J; Tumbo A; Mkindi C; Mpina M; Mtoro AT; Ishizuka AS; Kassim KR; Milando FA; Qassim M; Juma OA; Mwakasungula S; Simon B; James ER; Abebe Y; Kc N; Chakravarty S; Saverino E; Bakari BM; Billingsley PF; Seder RA; Daubenberger C; Sim BKL; Richie TL; Tanner M; Abdulla S; Hoffman SL
Am J Trop Med Hyg; 2018 Aug; 99(2):338-349. PubMed ID: 29943719
[TBL] [Abstract][Full Text] [Related]
7. Protection against
Epstein JE; Paolino KM; Richie TL; Sedegah M; Singer A; Ruben AJ; Chakravarty S; Stafford A; Ruck RC; Eappen AG; Li T; Billingsley PF; Manoj A; Silva JC; Moser K; Nielsen R; Tosh D; Cicatelli S; Ganeshan H; Case J; Padilla D; Davidson S; Garver L; Saverino E; Murshedkar T; Gunasekera A; Twomey PS; Reyes S; Moon JE; James ER; Kc N; Li M; Abot E; Belmonte A; Hauns K; Belmonte M; Huang J; Vasquez C; Remich S; Carrington M; Abebe Y; Tillman A; Hickey B; Regules J; Villasante E; Sim BKL; Hoffman SL
JCI Insight; 2017 Jan; 2(1):e89154. PubMed ID: 28097230
[No Abstract] [Full Text] [Related]
8. Multidose Priming and Delayed Boosting Improve Plasmodium falciparum Sporozoite Vaccine Efficacy Against Heterologous P. falciparum Controlled Human Malaria Infection.
Lyke KE; Singer A; Berry AA; Reyes S; Chakravarty S; James ER; Billingsley PF; Gunasekera A; Manoj A; Murshedkar T; Laurens MB; Church WP; Garver Baldwin LS; Sedegah M; Banania G; Ganeshan H; Guzman I; Reyes A; Wong M; Belmonte A; Ozemoya A; Belmonte M; Huang J; Villasante E; Sim BKL; Hoffman SL; Richie TL; Epstein JE;
Clin Infect Dis; 2021 Oct; 73(7):e2424-e2435. PubMed ID: 32920641
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Safety, Tolerability, and Immunogenicity of Plasmodium falciparum Sporozoite Vaccine Administered by Direct Venous Inoculation to Infants and Young Children: Findings From an Age De-escalation, Dose-Escalation, Double-blind, Randomized Controlled Study in Western Kenya.
Steinhardt LC; Richie TL; Yego R; Akach D; Hamel MJ; Gutman JR; Wiegand RE; Nzuu EL; Dungani A; Kc N; Murshedkar T; Church LWP; Sim BKL; Billingsley PF; James ER; Abebe Y; Kariuki S; Samuels AM; Otieno K; Sang T; Kachur SP; Styers D; Schlessman K; Abarbanell G; Hoffman SL; Seder RA; Oneko M
Clin Infect Dis; 2020 Aug; 71(4):1063-1071. PubMed ID: 31555824
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and Protective Efficacy of Radiation-Attenuated and Chemo-Attenuated PfSPZ Vaccines in Equatoguinean Adults.
Jongo SA; Urbano V; Church LWP; Olotu A; Manock SR; Schindler T; Mtoro A; Kc N; Hamad A; Nyakarungu E; Mpina M; Deal A; Bijeri JR; Ondo Mangue ME; Ntutumu Pasialo BE; Nguema GN; Owono SN; Rivas MR; Chemba M; Kassim KR; James ER; Stabler TC; Abebe Y; Saverino E; Sax J; Hosch S; Tumbo AM; Gondwe L; Segura JL; Falla CC; Phiri WP; Hergott DEB; García GA; Schwabe C; Maas CD; Murshedkar T; Billingsley PF; Tanner M; Ayekaba MO; Sim BKL; Daubenberger C; Richie TL; Abdulla S; Hoffman SL
Am J Trop Med Hyg; 2021 Jan; 104(1):283-293. PubMed ID: 33205741
[No Abstract] [Full Text] [Related]
12. Malaria transmission-blocking vaccines Pfs230D1-EPA and Pfs25-EPA in Alhydrogel in healthy Malian adults; a phase 1, randomised, controlled trial.
Sagara I; Healy SA; Assadou MH; Kone M; Swihart BJ; Kwan JL; Fintzi J; Sissoko K; Kamate B; Samake Y; Guindo MA; Doucoure M; Niaré K; Dolo A; Diarra B; Rausch KM; Narum DL; Jones DS; MacDonald NJ; Zhu D; Gorres JP; Imeru A; Mohan R; Thera I; Zaidi I; Salazar-Miralles F; Duan J; Neal J; Morrison RD; Muratova O; Sylla D; O'Connell EM; Wu Y; Hume JCC; Coulibaly MB; Anderson CF; Traore SF; Doumbo OK; Duffy PE
Lancet Infect Dis; 2023 Nov; 23(11):1266-1279. PubMed ID: 37499679
[TBL] [Abstract][Full Text] [Related]
13. Protective efficacy and safety of radiation-attenuated and chemo-attenuated Plasmodium Falciparum sporozoite vaccines against controlled and natural malaria infection: a systematic review and meta-analysis of randomized controlled trials.
Abuelazm MT; Elzeftawy MA; Kamal MA; Badr H; Gamal M; Aboulgheit M; Abdelazeem B; Abd-Elsalam S; Abouzid M
Infection; 2024 Jun; 52(3):707-722. PubMed ID: 38319556
[TBL] [Abstract][Full Text] [Related]
14. Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres.
Mordmüller B; Supan C; Sim KL; Gómez-Pérez GP; Ospina Salazar CL; Held J; Bolte S; Esen M; Tschan S; Joanny F; Lamsfus Calle C; Löhr SJ; Lalremruata A; Gunasekera A; James ER; Billingsley PF; Richman A; Chakravarty S; Legarda A; Muñoz J; Antonijoan RM; Ballester MR; Hoffman SL; Alonso PL; Kremsner PG
Malar J; 2015 Mar; 14():117. PubMed ID: 25889522
[TBL] [Abstract][Full Text] [Related]
15. Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial.
Oneko M; Steinhardt LC; Yego R; Wiegand RE; Swanson PA; Kc N; Akach D; Sang T; Gutman JR; Nzuu EL; Dungani A; Kim Lee Sim B; Oloo PN; Otieno K; Bii DK; Billingsley PF; James ER; Kariuki S; Samuels AM; Jongo S; Chebore W; Abdulla S; Daubenberger C; Mpina M; Styers D; Potter GE; Abarbanell G; Richie TL; Hoffman SL; Seder RA
Nat Med; 2021 Sep; 27(9):1636-1645. PubMed ID: 34518679
[TBL] [Abstract][Full Text] [Related]
16. Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults.
Jongo SA; Church LWP; Mtoro AT; Schindler T; Chakravarty S; Ruben AJ; Swanson PA; Kassim KR; Mpina M; Tumbo AM; Milando FA; Qassim M; Juma OA; Bakari BM; Simon B; James ER; Abebe Y; Kc N; Saverino E; Fink M; Cosi G; Gondwe L; Studer F; Styers D; Seder RA; Schindler T; Billingsley PF; Daubenberger C; Sim BKL; Tanner M; Richie TL; Abdulla S; Hoffman SL
Clin Infect Dis; 2020 Dec; 71(11):2849-2857. PubMed ID: 31782768
[TBL] [Abstract][Full Text] [Related]
17. Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults.
Jongo S; Church LWP; Milando F; Qassim M; Schindler T; Rashid M; Tumbo A; Nyaulingo G; Bakari BM; Athuman Mbaga T; Mohamed L; Kassimu K; Simon BS; Mpina M; Zaidi I; Duffy PE; Swanson PA; Seder R; Herman JD; Mendu M; Zur Y; Alter G; Kc N; Riyahi P; Abebe Y; Murshedkar T; James ER; Billingsley PF; Sim BKL; Richie TL; Daubenberger C; Abdulla S; Hoffman SL
J Clin Invest; 2024 Jan; 134(6):. PubMed ID: 38194272
[TBL] [Abstract][Full Text] [Related]
18. Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men.
Olotu A; Urbano V; Hamad A; Eka M; Chemba M; Nyakarungu E; Raso J; Eburi E; Mandumbi DO; Hergott D; Maas CD; Ayekaba MO; Milang DN; Rivas MR; Schindler T; Embon OM; Ruben AJ; Saverino E; Abebe Y; Kc N; James ER; Murshedkar T; Manoj A; Chakravarty S; Li M; Adams M; Schwabe C; Segura JL; Daubenberger C; Tanner M; Richie TL; Billingsley PF; Lee Sim BK; Abdulla S; Hoffman SL
Am J Trop Med Hyg; 2018 Jan; 98(1):308-318. PubMed ID: 29141739
[TBL] [Abstract][Full Text] [Related]
19. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection.
Lyke KE; Ishizuka AS; Berry AA; Chakravarty S; DeZure A; Enama ME; James ER; Billingsley PF; Gunasekera A; Manoj A; Li M; Ruben AJ; Li T; Eappen AG; Stafford RE; Kc N; Murshedkar T; Mendoza FH; Gordon IJ; Zephir KL; Holman LA; Plummer SH; Hendel CS; Novik L; Costner PJ; Saunders JG; Berkowitz NM; Flynn BJ; Nason MC; Garver LS; Laurens MB; Plowe CV; Richie TL; Graham BS; Roederer M; Sim BK; Ledgerwood JE; Hoffman SL; Seder RA
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2711-2716. PubMed ID: 28223498
[TBL] [Abstract][Full Text] [Related]
20. Safety and Differential Antibody and T-Cell Responses to the
Jongo SA; Church LWP; Mtoro AT; Chakravarty S; Ruben AJ; Swanson PA; Kassim KR; Mpina M; Tumbo AM; Milando FA; Qassim M; Juma OA; Bakari BM; Simon B; James ER; Abebe Y; Kc N; Saverino E; Gondwe L; Studer F; Fink M; Cosi G; El-Khorazaty J; Styers D; Seder RA; Schindler T; Billingsley PF; Daubenberger C; Sim BKL; Tanner M; Richie TL; Abdulla S; Hoffman SL
Am J Trop Med Hyg; 2019 Jun; 100(6):1433-1444. PubMed ID: 30994090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
